Abstract
Background
Both [F-18]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F–FDG PET/CT) and diagnostic CT are at times required for lymphoma staging. This means some body segments are exposed twice to X-rays for generation of CT data (diagnostic CT + localization CT).
Objective
To describe a combined PET/diagnostic CT approach that modulates CT tube current along the z-axis, providing diagnostic CT of some body segments and localization CT of the remaining body segments, thereby reducing patient radiation dose.
Materials and methods
We retrospectively compared total patient radiation dose between combined PET/diagnostic CT and separately acquired PET/CT and diagnostic CT exams. When available, we calculated effective doses for both approaches in the same patient; otherwise, we used data from patients of similar size. To confirm image quality, we compared image noise (Hounsfield unit [HU] standard deviation) as measured in the liver on both combined and separately acquired diagnostic CT images. We used t-tests for dose comparisons and two one-sided tests for image-quality equivalence testing.
Results
Mean total effective dose for the CT component of the combined and separately acquired diagnostic CT exams were 6.20±2.69 and 8.17±2.61 mSv, respectively (P<0.0001). Average dose savings with the combined approach was 24.8±17.8% (2.60±2.51 mSv [range: 0.32–4.72 mSv]) of total CT effective dose. Image noise was not statistically significantly different between approaches (12.2±1.8 HU vs. 11.7±1.5 HU for the combined and separately acquired diagnostic CT images, respectively).
Conclusion
A combined PET/diagnostic CT approach as described offers dose savings at similar image quality for children and young adults with lymphoma who have indications for both PET and diagnostic CT examinations.
Similar content being viewed by others
References
Barrington SF, Kirkwood AA, Franceschetto A et al (2016) PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study. Blood 127:1531–1538
Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068
Jimenez Londono GA, Garcia Vicente AM, Sanchez Perez V et al (2014) (1)(8)F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients. Eur J Radiol 83:2224–2230
Chalaye J, Luciani A, Enache C et al (2014) Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management. Leuk Lymphoma 55:2887–2892
la Fougere C, Pfluger T, Schneider V et al (2008) Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT. Nuklearmedizin 47:37–42
Morimoto T, Tateishi U, Maeda T et al (2008) Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: comparison of integrated PET/CT with or without contrast enhancement. Eur J Radiol 67:508–513
Pinilla I, Gomez-Leon N, Del Campo-Del Val L et al (2011) Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma. Q J Nucl Med Mol Imaging 55:567–575
Rodriguez-Vigil B, Gomez-Leon N, Pinilla I et al (2006) PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J Nucl Med 47:1643–1648
Alessio AM, Kinahan PE (2017) CT protocol selection in PET-CT imaging. Image Wisely. http://www.imagewisely.org/imaging-modalities/nuclear-medicine/articles/ct-protocol-selection. Accessed 23 Aug 2017
Alessio AM, Phillips GS (2010) A pediatric CT dose and risk estimator. Pediatr Radiol 40:1816–1821
Huda W, Ogden KM, Khorasani MR (2008) Converting dose-length product to effective dose at CT. Radiology 248:995–1003
McCollough C, Cody D, Edyvean S et al (2008) The measurement, reporting, and management of radiation dose in CT: report of AAPM task group 23. American Association of Physicists in Medicine, Alexandria
Yoneyama T, Tateishi U, Endo I et al (2014) Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET/CT. Eur J Radiol 83:1734–1739
Elstrom RL, Leonard JP, Coleman M et al (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19:1770–1773
Sabate-Llobera A, Cortes-Romera M, Mercadal S et al (2016) Low-dose PET/CT and full-dose contrast-enhanced CT at the initial staging of localized diffuse large B-cell lymphomas. Clin Med Insights Blood Disord 9:29–32
Schaefer NG, Hany TF, Taverna C et al (2004) Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging -- do we need contrast-enhanced CT? Radiology 232:823–829
Simpson WL Jr, Lee KM, Sosa N et al (2016) Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan. Leuk Lymphoma 57:1083–1093
van Hamersvelt HP, Kwee TC, Fijnheer R et al (2014) Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma? J Comput Assist Tomogr 38:620–625
Fabritius G, Brix G, Nekolla E et al (2016) Cumulative radiation exposure from imaging procedures and associated lifetime cancer risk for patients with lymphoma. Sci Rep 6:35181
Nievelstein RA, Quarles van Ufford HM, Kwee TC et al (2012) Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol 22:1946–1954
Hulme KW, Rong J, Chasen B et al (2011) A CT acquisition technique to generate images at various dose levels for prospective dose reduction studies. AJR Am J Roentgenol 196:W144–W151
Massoumzadeh P, Don S, Hildebolt CF et al (2009) Validation of CT dose-reduction simulation. Med Phys 36:174–189
Chiaravalloti A, Danieli R, Caracciolo CR et al (2014) Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT. Medicine 93:e50
Allen-Auerbach M, Yeom K, Park J et al (2006) Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. J Nucl Med 47:298–301
Aquino SL, Kuester LB, Muse VV et al (2006) Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Eur J Nucl Med Mol Imaging 33:692–696
Juergens KU, Weckesser M, Stegger L et al (2006) Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? Eur Radiol 16:1131–1137
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
A.T. Trout receives royalties from Elsevier for a nuclear medicine text. Z. Qi, E.L. Gates and M.M. O’Brien have no conflicts of interest to report.
Rights and permissions
About this article
Cite this article
Qi, Z., Gates, E.L., O’Brien, M.M. et al. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma. Pediatr Radiol 48, 196–203 (2018). https://doi.org/10.1007/s00247-017-4019-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-017-4019-2